drugset / Trial / NCT03058666
Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.
Timeline
- Start
- 2017-03-29
- Primary completion
- 2018-06-01
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calfactant | Protein / enzyme biologic | 210 mg/kg | Inhaled |